BeHealth Solutions has licensed its rights in SHUTi to Pear Therapeutics and no longer offers or supports that program. For information about the new, FDA-authorized, prescription digital therapeutic developed by Pear from SHUTi, please visit: www.somryst.com

For information about SHUTi research studies, please visit: https://med.virginia.edu/bht/participate/